Sodium bicarbonate therapy
Bicarbonate · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Isotonic 1.26% and hypertonic 8.4% (1 mmol/mL) solutions. Real indications are narrow: urinary alkalinisation (salicylates, rhabdomyolysis), sodium-channel-blocker (TCA) toxicity, severe hyperkalaemia (adjunct), and selected severe metabolic acidosis with AKI (BICAR-ICU signal pH <7.20 + AKI).
Red flags
- Extravasation of 8.4% causes necrosis — large vein/central line
- A ventilated patient with fixed minute volume will retain the CO₂ generated — increase ventilation
Management
- Do NOT give bicarbonate for acidosis of tissue hypoperfusion — treat the perfusion; CO₂ generated can worsen INTRACELLULAR acidosis if ventilation cannot increase
- TCA toxicity with broad QRS: 8.4% boluses 1–2 mL/kg titrated to QRS narrowing/pH 7.45–7.55
- Alkaline diuresis (salicylate): 1.26% infusion targeting urine pH >7.5 — replace potassium or it fails
- Severe AKI acidosis pH <7.2: consider 1.26% infusion while arranging RRT
- Monitor: Na⁺ load, ionised calcium (falls with alkalinisation), K⁺ shifts, PaCO₂
A targeted antidote and alkalinising tool — not a treatment for “a bad gas”.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.